Aug 19 (Reuters) - European Medicines Agency:
* EMA: EMA’S EMERGENCY TASK FORCE ADVISES ON INTRADERMAL USE OF IMVANEX / JYNNEOS AGAINST MONKEYPOX : 19/08/2022
* EMA: ETF CAUTIONED HIGHER RISK OF LOCAL REACTIONS (E.G. LONGER-LASTING REDNESS, THICKENING OR DISCOLORATION OF SKIN) AFTER INTRADERMAL INJECTIONS
* EMA: NATIONAL AUTHORITIES MAY DECIDE TO USE IMVANEX TEMPORARILY AS INTRADERMAL INJECTION AT LOWER DOSE TO PROTECT AT-RISK INDIVIDUALS
